Invention Grant
US08212033B2 Use of substituted quinazoline compounds in treating angiogenesis-related diseases
有权
取代喹唑啉化合物在治疗血管生成相关疾病中的应用
- Patent Title: Use of substituted quinazoline compounds in treating angiogenesis-related diseases
- Patent Title (中): 取代喹唑啉化合物在治疗血管生成相关疾病中的应用
-
Application No.: US12893872Application Date: 2010-09-29
-
Publication No.: US08212033B2Publication Date: 2012-07-03
- Inventor: Wei-Guo Su , Weihan Zhang , Xiaoqiang Yan , Yumin Cui , Yongxin Ren , Jifeng Duan
- Applicant: Wei-Guo Su , Weihan Zhang , Xiaoqiang Yan , Yumin Cui , Yongxin Ren , Jifeng Duan
- Applicant Address: BS Nassau
- Assignee: Hutchison Medipharma Enterprises Limited
- Current Assignee: Hutchison Medipharma Enterprises Limited
- Current Assignee Address: BS Nassau
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Main IPC: C07D239/72
- IPC: C07D239/72
Abstract:
Quinazoline derivatives of the following formula: wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, and Z are defined herein. It also discloses a method of treating an angiogenesis-related disorder with one of these compounds.
Public/Granted literature
- US20110015213A1 QUINAZOLINE DERIVATIVES Public/Granted day:2011-01-20
Information query
